Combination of biotransformation by P450 BM3 mutants with on-line post-column bioaffinity and mass spectrometric profiling as a novel strategy to diversify and characterize p38α kinase inhibitors

Maarten Honing, Vanina Rea, David Falck, Jeroen Kool, Frans J. J. de Kanter, Jan N. M. Commandeur, Nico P. E. Vermeulen, Wilfried M. A. Niessen
  • MedChemComm, January 2013, Royal Society of Chemistry
  • DOI: 10.1039/c2md20283b
The author haven't yet claimed this publicationThe author haven't yet claimed this publication